Blood biomarker mix could foresee Alzheimer's risk years before symptoms
TL;DR Summary
A University of Miami study of 1,170 older adults found that blood biomarkers, notably p-tau181 and GFAP, correlate with future cognitive decline years after initial testing, suggesting a combined blood test could flag people at higher risk of cognitive problems before memory loss appears—though it would not predict dementia on its own.
- Simple Blood Test Could Flag Your Memory Problems 6 Years Before They Start ScienceAlert
- Scientists May Have Found How to Predict When Alzheimer’s Signs Will Begin Newsweek
- Researchers warn social media driving harmful misuse of Alzheimer’s blood tests The Guardian
- EYE ON HEALTH: New Alzheimer's Blood Test Available in Dalton Local 3 News
- As Alzheimer’s Blood Tests Jockey for Market Share, Convenience and Cost Will Be Key genomeweb.com
Reading Insights
Total Reads
1
Unique Readers
5
Time Saved
5 min
vs 6 min read
Condensed
95%
1,013 → 52 words
Want the full story? Read the original article
Read on ScienceAlert